CH

ABOUT US

ABOUT US

2016

Hanpeptide Biomedical Group Co., LTD., founded in Zibo Intertech Teide Biomedical Technology Co., LTD., was registered and established in Zibo Economic and Technological Development Zone, Shandong Province in 2016. Its business direction is research and development of chemical and biological drugs, pharmaceutical intermediates and drugs, etc.

2018

After two years of market research and development of technology accumulation and development, in order to make full use of zibo in shandong university institute of biomedical research and development environment, on February 8, 2018 in shandong zibo high-tech biological medicine research institute of the han tai biotechnology co., LTD., the original Internet ted company become a wholly owned company, the company continue to shoulder some of the product research and development tasks.

2018

After two years of market research and development of technology accumulation and development, in order to make full use of zibo in shandong university institute of biomedical research and development environment, on February 8, 2018 in shandong zibo high-tech biological medicine research institute of the han tai biotechnology co., LTD., the original Internet ted company become a wholly owned company, the company continue to shoulder some of the product research and development tasks.

2019

In order to accelerate the transformation and industrialization of scientific and technological achievements, Shandong Hanpeptide Biomedical Co., Ltd. was established in June 2019 in The Economic and Technological Development Zone of Yiyuan County, Zibo city. All the r&d assets and personnel of the former Shandong Hantai Biological Technology Co., Ltd. were integrated into the Hanpeptide Biological RESEARCH and Development Center.

2020

Tianshan Wool Tex Stock Co., Ltd., through investment and acquisition, becomes the controlling shareholder of the company, which welcomes a broader development space for the company.The company has successively established the "Three centers and three projects production base of The Two Houses", and integrated all branches and subsidiaries. The company officially changed its name from Shandong Hanpeptide Biomedical Co., Ltd. to Hanpeptide Biomedical Group Co., LTD.The marketing team of Hanpeptide Biotechnology will redouble its efforts to bring better products to customers and create more returns for shareholders.

2020

Tianshan Wool Tex Stock Co., Ltd., through investment and acquisition, becomes the controlling shareholder of the company, which welcomes a broader development space for the company.The company has successively established the "Three centers and three projects production base of The Two Houses", and integrated all branches and subsidiaries. The company officially changed its name from Shandong Hanpeptide Biomedical Co., Ltd. to Hanpeptide Biomedical Group Co., LTD.The marketing team of Hanpeptide Biotechnology will redouble its efforts to bring better products to customers and create more returns for shareholders.

版权所有 © 汉肽生物医药集团 鲁ICP备069573500456号

Scan follows the public account